Eicosanoids in regulation of arterial smooth muscle cell phenotype, proliferative capacity, and cholesterol metabolism.
Year: 1989
Type: review
Abstract: E icosanoids, particularly prostacyclin (PGI 2 ) and throm- boxane A 2 (TxA 2 ), have been implicated in the regulation of vascular homeostasis from the point of view of platelet-vessel wall interactions and in the regulation of blood vessel tone and hemostasis (for reviews, see references 1 and 2).However, subsequent investigations have revealed that PGI 2 and other eicosanoids may also have an important role in the regulation of arterial smooth muscle cell phenotype and cellular cholesterol metabolism.The purpose of this review is to summarize recent findings on the role of eicosanoids in the regulation of smooth muscle cell proliferative capacity and cellular cholesterol content under normal physiological conditions and in an "atherogenic" environment. Evidence Implicating Eicosanoids In AtherosclerosisIt is now well established that oxygenated metabolites of arachidonic acid (a polyunsaturated fatty add derived from chain elongation and delta-9 desaturation of linoleic acid), namely prostaglandins, leukotrienes, and hydroxyeicosatetraenoic acids (HETEs), may play a role In vascular homeostasis.PGI 2 is the principal arachidonic acid metabolite synthesized by arterial tissue principally by endothelium and, to a lesser extent, by underlying medial smooth muscle cells.Prostaglandin E 2 (PGE 2 ) and prostaglandin F^ (PGF^,) are also synthesized by vascular endothelium and smooth muscle cells, but to a much lesser extent.On the other hand, platelets synthesize From the Departments of Medicine, Pathology, and Biochemistry and the National Institutes
Authors: K B Pomerantz, D P Hajjar
Institution: Cornell University
Language: English
Subfield: Biochemistry
Domain: Life Sciences
Open Access status: diamond
OpenAlex ID: W2047104741
